Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

Elevated hepatic iron activates NF-E2-related factor 2-regulated pathway in a dietary iron overload mouse model.

Moon MS, McDevitt EI, Zhu J, Stanley B, Krzeminski J, Amin S, Aliaga C, Miller TG, Isom HC.

Toxicol Sci. 2012 Sep;129(1):74-85. doi: 10.1093/toxsci/kfs193. Epub 2012 May 30.

2.

3,5,5-trimethyl-hexanoyl-ferrocene diet protects mice from moderate transient acetaminophen-induced hepatotoxicity.

Moon MS, Kang BH, Krzeminski J, Amin S, Aliaga C, Zhu J, McDevitt EI, Kocher S, Richie JP, Isom HC.

Toxicol Sci. 2011 Dec;124(2):348-58. doi: 10.1093/toxsci/kfr231. Epub 2011 Sep 9.

3.

Regression of established hepatocellular carcinoma is induced by chemoimmunotherapy in an orthotopic murine model.

Avella DM, Li G, Schell TD, Liu D, Zhang SS, Lou X, Berg A, Kimchi ET, Tagaram HR, Yang Q, Shereef S, Garcia LS, Kester M, Isom HC, Rountree CB, Staveley-O'Carroll KF.

Hepatology. 2012 Jan;55(1):141-52. doi: 10.1002/hep.24652.

4.

Nanoliposomal ceramide prevents in vivo growth of hepatocellular carcinoma.

Tagaram HR, Divittore NA, Barth BM, Kaiser JM, Avella D, Kimchi ET, Jiang Y, Isom HC, Kester M, Staveley-O'Carroll KF.

Gut. 2011 May;60(5):695-701. doi: 10.1136/gut.2010.216671. Epub 2010 Dec 30.

PMID:
21193455
5.

Iron potentiates acetaminophen-induced oxidative stress and mitochondrial dysfunction in cultured mouse hepatocytes.

Moon MS, Richie JP, Isom HC.

Toxicol Sci. 2010 Nov;118(1):119-27. doi: 10.1093/toxsci/kfq230. Epub 2010 Jul 28.

6.

Elevated hepatic iron: a confounding factor in chronic hepatitis C.

Isom HC, McDevitt EI, Moon MS.

Biochim Biophys Acta. 2009 Jul;1790(7):650-62. doi: 10.1016/j.bbagen.2009.04.009. Epub 2009 Apr 23. Review.

PMID:
19393721
7.

trans-Complementation of HBV rtM204I mutant replication by HBV wild-type polymerase.

Heipertz RA Jr, Starkey JL, Miller TG, Hu J, Isom HC.

Virology. 2009 May 25;388(1):57-67. doi: 10.1016/j.virol.2009.03.018. Epub 2009 Apr 19.

9.

Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) attenuates carbon tetrachloride hepatotoxicity by downregulating proinflammatory gene expression.

Shan W, Palkar PS, Murray IA, McDevitt EI, Kennett MJ, Kang BH, Isom HC, Perdew GH, Gonzalez FJ, Peters JM.

Toxicol Sci. 2008 Oct;105(2):418-28. doi: 10.1093/toxsci/kfn142. Epub 2008 Jul 12.

10.

In vitro study of the effects of precore and lamivudine-resistant mutations on hepatitis B virus replication.

Heipertz RA Jr, Miller TG, Kelley CM, Delaney WE 4th, Locarnini SA, Isom HC.

J Virol. 2007 Apr;81(7):3068-76. Epub 2007 Jan 10.

11.

Baculovirus-mediated gene transfer for the study of hepatitis B virus.

Isom HC, Abdelhamed AM, Bilello JP, Miller TG.

Methods Mol Med. 2004;96:219-37. No abstract available.

PMID:
14762273
12.
13.
14.

Role of paracellular junction complexes in baculovirus-mediated gene transfer to nondividing rat hepatocytes.

Bilello JP, Cable EE, Myers RL, Isom HC.

Gene Ther. 2003 May;10(9):733-49.

PMID:
12704412
15.
16.

Comparison of anti-hepatitis B virus activities of lamivudine and clevudine by a quantitative assay.

Abdelhamed AM, Kelley CM, Miller TG, Furman PA, Cable EE, Isom HC.

Antimicrob Agents Chemother. 2003 Jan;47(1):324-36.

17.

Rebound of hepatitis B virus replication in HepG2 cells after cessation of antiviral treatment.

Abdelhamed AM, Kelley CM, Miller TG, Furman PA, Isom HC.

J Virol. 2002 Aug;76(16):8148-60.

20.

Transient disruption of intercellular junctions enables baculovirus entry into nondividing hepatocytes.

Bilello JP, Delaney WE 4th, Boyce FM, Isom HC.

J Virol. 2001 Oct;75(20):9857-71.

22.

Cross-resistance testing of antihepadnaviral compounds using novel recombinant baculoviruses which encode drug-resistant strains of hepatitis B virus.

Delaney WE 4th, Edwards R, Colledge D, Shaw T, Torresi J, Miller TG, Isom HC, Bock CT, Manns MP, Trautwein C, Locarnini S.

Antimicrob Agents Chemother. 2001 Jun;45(6):1705-13.

23.

A selection system for identifying accessible sites in target RNAs.

Pan WH, Devlin HF, Kelley C, Isom HC, Clawson GA.

RNA. 2001 Apr;7(4):610-21.

26.
30.
31.

Tumor necrosis factor-alpha-induced apoptosis in hepatocytes in long-term culture.

Bour ES, Ward LK, Cornman GA, Isom HC.

Am J Pathol. 1996 Feb;148(2):485-95.

33.

Responsiveness of an SV40-immortalized hepatocyte cell line to growth hormone.

Kempe KC, Isom HC, Greene FE.

Biochem Pharmacol. 1995 Apr 18;49(8):1091-8.

PMID:
7748190
34.
35.
36.
37.
38.

Functional analyses of albumin expression in a series of hepatocyte cell lines and in primary hepatocytes.

Hu JM, Camper SA, Tilghman SM, Miller T, Georgoff I, Serra R, Isom HC.

Cell Growth Differ. 1992 Sep;3(9):577-88.

39.
40.
41.

Guinea pig cytomegalovirus immediate-early transcription.

Yin CY, Gao M, Isom HC.

J Virol. 1990 Apr;64(4):1537-48.

42.

Cellular localization of cytomegalovirus nucleic acids in guinea pig salivary glands by in situ hybridization.

Griffith BP, Isom HC, Lavallee JT.

J Virol Methods. 1990 Feb;27(2):145-57.

PMID:
2156878
43.

Guinea pig cytomegalovirus gene expression.

Isom HC, Yin CY.

Curr Top Microbiol Immunol. 1990;154:101-21. Review. No abstract available.

PMID:
2161318
44.

Stimulation of the acute-phase response in simian virus 40-hepatocyte cell lines.

Liao WS, Ma KT, Woodworth CD, Mengel L, Isom HC.

Mol Cell Biol. 1989 Jul;9(7):2779-86.

45.

Association of newly synthesized poly(A) polymerase with four distinct polypeptides.

Hengst JA, Georgoff I, Isom HC, Jacob ST.

J Biol Chem. 1988 Dec 25;263(36):19270-3.

46.
47.

Hormonal regulation of pseudocholinesterase activity in cultured rat hepatocytes.

Cammisa HM, Isom HC, Greene FE.

Endocrinology. 1988 Mar;122(3):991-6.

PMID:
3342764
48.
50.

Detection of guinea pig cytomegalovirus nucleic acids in cultured cells with biotin-labelled hybridization probes.

Sha M, Griffith BP, Raveh D, Isom HC, Ward DC, Hsiung GD.

Virus Res. 1987 Jan;6(4):317-29.

PMID:
3031892

Supplemental Content

Support Center